AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Debt / NOTE 2.000% 8/1
Market price (% of par)
70.0%
Total 13F principal
$52,392,000
Principal change
-$223,530,000
Total reported market value
$36,674,000
Number of holders
1
Value change
-$158,977,000
Number of buys
1
Number of sells
11

Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q2 2019

As of 30 Jun 2019 AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 had 1 institutional bondholder that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of $52,392,000 principal (par value or face value) of the bond of the company.
Largest 1 bondholders included EdgePoint Investment Group Inc..
This table shows 1 bond principal holders of the security as of 30 Jun 2019.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.